Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

517 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.
Alcantara M, Mezei MM, Baker SK, Breiner A, Dhawan P, Fiander A, Fine NM, Hahn C, Katzberg HD, Khayambashi S, Massie R, Matte G, Putko B, Siddiqi Z, Delgado D, Bril V. Alcantara M, et al. Among authors: delgado d. Can J Neurol Sci. 2022 Jan;49(1):7-18. doi: 10.1017/cjn.2021.34. Epub 2021 Feb 26. Can J Neurol Sci. 2022. PMID: 33631091 Review.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
Di Giovanni B, Gustafson D, Delgado DH. Di Giovanni B, et al. Among authors: delgado dh. Expert Rev Cardiovasc Ther. 2019 Sep;17(9):673-681. doi: 10.1080/14779072.2019.1662723. Epub 2019 Sep 3. Expert Rev Cardiovasc Ther. 2019. PMID: 31478389 Review.
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
O'Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D'Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B. O'Meara E, et al. Among authors: d astous m, delgado dh. Can J Cardiol. 2020 Feb;36(2):159-169. doi: 10.1016/j.cjca.2019.11.036. Can J Cardiol. 2020. PMID: 32036861
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
Fine NM, Davis MK, Anderson K, Delgado DH, Giraldeau G, Kitchlu A, Massie R, Narayan J, Swiggum E, Venner CP, Ducharme A, Galant NJ, Hahn C, Howlett JG, Mielniczuk L, Parent MC, Reece D, Royal V, Toma M, Virani SA, Zieroth S. Fine NM, et al. Among authors: delgado dh. Can J Cardiol. 2020 Mar;36(3):322-334. doi: 10.1016/j.cjca.2019.12.034. Can J Cardiol. 2020. PMID: 32145862
Hereditary transthyretin amyloidosis: a case report.
Lee A, Fine NM, Bril V, Delgado D, Hahn C. Lee A, et al. Among authors: delgado d. J Med Case Rep. 2022 Jun 25;16(1):248. doi: 10.1186/s13256-022-03437-0. J Med Case Rep. 2022. PMID: 35751086 Free PMC article.
Hiding in Plain Sight: Cardiac Amyloidosis, an Emerging Epidemic.
Di Giovanni B, Gustafson D, Adamson MB, Delgado DH. Di Giovanni B, et al. Among authors: delgado dh. Can J Cardiol. 2020 Mar;36(3):373-383. doi: 10.1016/j.cjca.2019.12.015. Epub 2019 Dec 17. Can J Cardiol. 2020. PMID: 32145865 Review.
517 results